ACR Convergence 2025| Video: Rheuminations on Milestones & Ageism

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • Technology
      • Information Technology
      • Apps
    • QA/QI
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
      • Education & Training
    • Certification
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: FLARE

Survey Highlights High Out-of-pocket Costs for RA Care

Richard Quinn  |  October 25, 2013

The “RA in America 2013″ survey estimates out-of-pocket cost for RA treatment at  $1,000 to $5,000 per year. (posted Oct. 25)

Filed under:ConditionsResearch RheumRheumatoid Arthritis Tagged with:Out-of-pocket costsPatient costsRARheumatoid arthritisTreatment costs

New Insights into CPPD

Robert Terkeltaub, MD  |  October 1, 2013

Progress in research, outcomes, diagnosis, and treatment of calcium pyrophosphate dihydrate crystal deposition disease

Filed under:ConditionsGout and Crystalline ArthritisResearch Rheum Tagged with:DiseaseResearchTreatment

Speak Out Rheum: Under the Radar

Sarah Schafer, MD  |  September 10, 2013

A physician–patient’s experience with Sjögren’s syndrome

Filed under:ConditionsSjögren’s Disease Tagged with:Dry eyeSjogren's

Rheum with a View: How Should We Train Rheumatology Fellows?

Richard S. Panush, MD  |  August 1, 2013

Regulatory mandates in the ACGME’s Next Accreditation System aim to improve the way rheumatologists are trained, but they might not have the desired effect

Filed under:Education & TrainingProfiles Tagged with:accreditationACGMEEducationrheumatologyTraining

California Rheumatology Alliance 2013 Meeting: Rheumatologists Advised to Drop Prednisone Maintenance Therapy in Lupus Patients

Stephanie Cajigal  |  July 1, 2013

A systemic lupus erythematosus (SLE) disease expert emphasizes benefits of hydroxychloroquine, burst of steroid treatments

Filed under:ConditionsDrug UpdatesSystemic Lupus Erythematosus Tagged with:HYDROXYCHLOROQUINELupusprednisoneSLETreatment

Rheumatology Drug Updates

Michele B. Kaufman, PharmD, BCGP  |  July 1, 2013

Information on new approvals and medication safety that rheumatologists need to know

Filed under:Drug Updates Tagged with:ApprovalsglucosamineopioidPipelineSafety

What Adult Rheumatologists Need to Know about Juvenile Arthritis

Peter A. Nigrovic, MD  |  May 1, 2013

How to recognize distinctions between pediatric and adult arthritis

Filed under:ConditionsOther Rheumatic Conditions Tagged with:ClinicalJuvenile arthritispatient care

Rheuminations: Circadian Rhythms May Play Role in Inflammatory Disease

Simon M. Helfgott, MD  |  May 1, 2013

Research into how the timing of light and dark exposures control our lives could provide clues to why some people have immunologic disorders

Filed under:OpinionResearch RheumRheuminationsSpeak Out Rheum Tagged with:Inflammatory DiseaseResearchrheumatology

ACR Winter Rheumatology Symposium: Tips for ANCA Testing

Kimberly Retzlaff  |  May 1, 2013

How to select the correct testing method and interpret conflicting results from antineutrophil cytoplasmic antibody tests

Filed under:ConditionsMeeting Reports Tagged with:ACR Winter Rheumatology Symposiumantineutrophil cytoplasmic antibodyTesting

Is Predisone 3 mg/day an Appropriate Dose for Patients with Rheumatoid Arthritis?

Theodore Pincus, MD  |  April 1, 2013

 Long-term, low-dose prednisone at less than 5 mg/day appears tolerable and effective for many patients with rheumatoid arthritis (RA)

Filed under:ConditionsDrug UpdatesRheumatoid Arthritis Tagged with:GlucocorticoidsprednisoneRARheumatoid arthritis

  • « Previous Page
  • 1
  • …
  • 60
  • 61
  • 62
  • 63
  • 64
  • …
  • 70
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences